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ABSTRACT
The neural cell adhesion molecule (N-CAM) is an
important mediator of calcium independent cell-cell
Interactions. Variations in the primary structure of the
protein are due to alternative splicing of pre-mRNA in
the region encoding the extracellular, trans-membrane
and cytoplasmic domains. In order to identify the
patterns of exon usage during development of skeletal
muscle and brain of the mouse, a coupled reverse-
transcriptase/polymerase chain reaction was used to
identify the murine homologues of the muscle-specific
domain (MSD), located between exons 12 and 13 in
human N-CAM mRNA. The cDNAs produced have been
cloned and sequenced, or analysed directly. The
amplification reactions were shown to maintain the
concentration ratios of the Initial cDNAs. The results
indicate that the mouse homologue to exon MSD1a is
under tissue and developmental regulation that Is
independent of exons MSD1b and MSD1c. The
inclusion of the triplet exon AAG is also regulated in
a cell- and stage-specific manner, which is independent
of the other alternatively spliced exons of this domain.
INTRODUCTION
Neural cell adhesion molecules (N-CAMs) are a group of cell-
surface sialoglycoproteins which belong to the immunoglobulin
gene superfamily. Proteins of this superfamily are characterised
by extracellular regions of /3-pleated sheet stabilised by disulphide
bridges ('Ig folds')1. N-CAM mediates calcium-independent
interactions between cells; homophilic binding of N-CAMs on
apposing cells results in enhanced or extended interactions
between cells. These interactions are modulated by post-
translational modifications involving the developmentally-
regulated attachment of an unusual polysialic acid (PSA)-
containing carbohydrate structure2. Sites involved in homophilic
binding have been localised to two regions within the first three
Ig-folds1.
A number of isoforms of N-CAM have been reported which
differ in their mode of membrane attachment and in cytoplasmic
domain structure, although only a single N-CAM gene has been
demonstrated in a variety of species. Based on analysis of cDNA
clones from a variety of organisms3-4-5-6, these isoforms appear
to arise from patterns of alternative splicing that are determined
in a developmental and tissue-specific manner7'8. Alternative
splicing gives rise to two additional regions of diversity, both
in the extracellular domain. Variants include novel sequence
segments between exons 7 and 89-10, involving the fourth Ig
domain, and also between exons 12 and 138.11.12^
 m m e
membrane proximal 'stem' structure of N-CAM polypeptides.
In the latter instance, an alternatively-spliced sequence block of
4 exons (MSDla, MSDlb, MSDlc, and triplet AAG)) has been
described in chick and human N-CAM mRNA in striated muscle
tissues; this has been termed the muscle specific domain (MSD).
The unusual 3 base pair insert (triplet AAG) is not due to allelic
variation13. Cell transfection studies using full-length cDNA
clones have further indicated that expression of isoforms
containing the MSD region in cultured muscle cells results in
enhanced fusion of mononucleate precursor myoblasts into
differentiated multinucleate myotubes. Part of the muscle-specific
domain (MSD) introduces a string of proline residues which may
induce a bend or hinge in the molecule; this may affect either
rra/ts-acting homophilic binding or cell-cell interaction via a ex-
acting effect on interaction with other cell-surface adhesion
molecules14. The MSD is a site of extensive post-translational
modification with O-linked carbohydrate, which is characteristic
of hinge regions in other Ig superfamily members15. The
genomic sequences of two exons of the MSD (lb and lc ) have
been identified in the human16 although only the homologue to
exon MSDla and a putative site for the triplet exon AAG have
been identified in a genomic clone from the mouse9. The exons
of this domain are unusually short: 15, 48, 42 and 3 base pairs
long for MSD la, MSD lb, MSD lc and triplet AAG
respectively.
Although the human MSD has been found as a single unit in
skeletal muscle, evidence has accumulated for the individual
regulation of at least 2 of its constituent exons. This is clearly
the case for exon MSDla in the mouse, which has been found
without exons MSDlb and MSD lc in neural tissue. In order
to establish whether the component exons of the MSD are
regulated collectively, by splicing during muscle development,
we have characterized fully the mouse homologues of the MSD
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exons described previously in the chick17, human" and rat8and
we have examined in detail the patterns during brain and in
particular during skeletal muscle development.
MATERIALS AND METHODS
Cell and tissue samples
Skeletal muscle (lower hind limb) and brain tissues were dissected
from embryonic (El6), newborn (post natal 3 day), and adult
(10 week old) Balb c mice. Samples of denervated adult mouse
muscle were obtained 7 days after surgical section of the sciatic
nerve as previously described18. Mouse C-2 myoblasts were
grown as described previously7, and mid-fusion and myotube
samples were obtained 2 and 4 days following initiation of
myogenic differentiation by switching cultures into medium
containing horse serum. N2A neuroblastoma, C6 glioma and
SWA schwannoma cells15 were grown to confluence before
harvesting for RNA preparation.
RNA preparation
RNA was extracted from cell lines and mouse tissues by the
addition of 4ml 3M LiCl /6M urea19. Tubes were incubated
on ice for at least 2 hours then centrifuged at 10,000rpm for
30 minutes. The pellet was washed with cold LiCl/urea
and resuspended in 300/il TE. 1/0.5% SDS. Three
chloroform/isoamyl alcohol extractions were performed and the
RNA finally precipitated with ethanol/sodium acetate (20/1) and
stored at -70°C.
Poly(A)+ RNA was isolated from total RNA using either the
spun columns available from Pharmacia, or with mAP™ paper
from Amersham, following the protocol for small sample
volumes. Both methods gave comparable results for isoform
variation in adult mouse brain and adult muscle when analysed
by RT-PCR (data not shown).
RT-PCR
25pmol of oligonucleotide MH2b (GCCGGCGCGGAGCTTT-
CTGCCCTTCCAGCTTGGGT), complementary to the
constitutive downstream exon 13, was added to poly(A)+ RNA
purified from 5/tg total RNA in a buffer containing 200/tM
dNTPs, 50mM KC1, lOmM Tris-HCl pH 8.0, 1.5mM MgCl2.
The RNA was denatured at 90° C for 5 minutes then cooled on
ice. 20 units of RNAguard™ was added and the primer allowed
to anneal at 65°C for 5 minutes. 10 units of MMuLV Reverse
Transcriptase (RT) was added and the reaction incubated at 37 °C
for one hour. The first strand cDNA was amplified by the addition
of 20pmol MHlb2(CCCCCGCCCCGAATTCCCACTGAGTT-
CAAGACACAG) oligonucleotide and a further lOpmol MH2b,
and 2 units of Taq polymerase to give a final volume of 100/tl
in the same buffer. Samples were overlaid with paraffin and
amplified by 30 cycles of: 92°C denaturation for 1.5 minutes,
65°C annealing for 1.5 minutes, and 72°C extension for 2
minutes. Final steps comprised annealing at 65°C annealing for
1.5 minute and extension at 72°C for 5 minutes to ensure that
full length double stranded PCR products were formed.
Cloning and sequencing of cDNA
The cDNA products were cut with Hindm and EcoRI in standard
reaction buffers and cloned into cut mICE 1820. Ligations were
transfected into competent JM109 cells. % plaques from each
cDNA cloning were selected and grown in 250/tl TY broth in
microtitre plates with constant shaking for 9 hours. Single
stranded template was prepared as described21, except that the
cells were removed by centrifugation rather than filtration. 150/tl
of supernatant was transferred into a second microtitre plate.
ssDNA was precipitated by the addition of 30/il PEG/NaCl
(20%/2.5M). After 10 minutes the plates were centrifuged at
3,000xg, and the supernatant discarded. Pellets were
resuspended in 50/tl TE.l/ 1% SDS and incubated at 70°C for
10 minutes. DNA was finally precipitated by the addition of
ethanol/sodium acetate (20/1), washed with 70% ethanol and
resuspended in TE.l. Sequencing reactions were as described22.
Direct analysis of amplified products
l/100th of a first round RT-PCR was transferred to a second
PCR. The amplification of the substrate was undertaken using
lOpmol of a nested oligonucleotide MH exl3 (AACCCAGTGC-
ACCCAAG) internal to the cDNA product from the first round
amplification, with lOpmol MH2b. 2.5/iCi [a-32P] dATP was
added to each reaction containing 200/iM dNTPs, 50mM KC1,
lOmM Tris-HCl pH 8.0, 1.5mM MgCl2. Samples were overlaid
with paraffin and amplified for 15 cycles of denaturation (92°C,
1.5 minutes), annealing(65°C, 1.5 minutes), extension (72°C,
2 minutes), followed by 59°C for 1.5 minutes and 72°C for 5
minutes. After precipitation with ethanol, samples were loaded
onto 10% native polyacrylamide gels.
Identification of PCR products
The identity of bands separated on native polyacrylamide gels
was confirmed by the direct sequencing of re-amplified excised
bands. End-labelled oligonucleotide MH exl3 and
dideoxynucleoside triphosphate were used in a PCR.
RESULTS
Cloning of mouse homologue to human MSD region
The region of murine N-CAM equivalent to that between exons
12 and 13 (containing the possible MSD homologue) was
amplified from cDNA by PCR (Figure 1). The products were
cloned and the sequences determined for 78 clones, 34 of which
were derived from myoblast RNA and 44 from myotube RNA.
Ten of the clones incorporated all of the exons homologous to
the human MSDla, MSDlb, MSDlc and triplet AAG exons.
Figure 2 shows such a cDNA sequence, flanked by regions of
the constitutive exons 12 and 13, aligned with the MSD exons
identified in the human and chicken. The other cDNA clones
contained various combinations of these exons, and are illustrated
in Figure 3.
The sequence analysis produced statistically significant figures
for the proportions of the major mRNA forms in myoblasts and
myotubes. Figure 3 indicates the putative alternative splicing
patterns required to produce the alternative forms, and the
distribution of variant forms within each cell type. Significant
differences (P< 0.005) are noted for the exon usage in
undifferentiated myoblasts and differentiated myotubes. These
clones include several unreported combinations of exons between
the constitutive exons 12 and 13, in the region homologous to
human MSD (12-a-b-c-13, 12-a-b-c-AAG-13,12-a-c-13, and
12-C-AAG-13).
Quantification of PCR products
The analysis described above involved reverse transcription,
amplification and cloning reactions. Although reverse
transcription is unlikely to preserve perfectly the original
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proportions of isoforms, especially when they differ in length,
it is a standard method for determining the ratios of mRNA and
difficult to circumvent. However, it was particularly important
to validate the amplification reaction, both because of the potential
for gross distortions of the proportions of isoforms and because
we wanted to use a second amplification reaction, with the
products of the first amplification reaction as substrates, in order
to visualise the ratios of the products directly rather than via
cloning and sequence analysis. If valid, this approach would allow
more significant values to be determined for rare events. In order
to test whether the proportions of substrate cDNA were
maintained during amplification, independent of the starting
concentrations of the substrate, two cDNA sequences were
amplified for 15 cycles in a series of reactions where their relative
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Figure 1. Strategies for analysis of N-CAM splicing between exons 12 and 13. A combined RT-PCR produced heterogeneous fragments by the amplification of
sequences flanked by the constitutive exons 12 and 13 of N-CAM. The inclusion of EcoRI and Hindin restriction sites in the sequence of the oligonucleotide primers
allowed for the subsequent ligation of products into a vector for sequence analysis. An aliquot of the heterogeneous PCR product was also used as a substrate for
two second round PCRs using primers directed against part of exon 13 in conjunction with the primer against exon 12, or with a primer directed against exon MSDlc.
The incorporation of a[32P] dATP into these reactions enabled the products to be visualised by their separation on native polyacrylamide gels. Oligonucleotide sequences
are represented as clear for regions of exon complimentarity; solid boxes for mismatched restriction sites; and shaded boxes for flanking GC-rich 'clamps'. Exon
sequences are shown as clear boxes for the constitutive exons 12 and 13, vertical hatching for MSDla, pale hatching for MSDlb, dark hatching for MSDlc, and
solid boxes for the triplet exon AAG.
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Figure 2. cDNA sequence of the mouse exons homologous to human MSDla, MSDlb, MSDlc and the triplet AAG, flanked by regions of the constitutive exons
12 and 13 of N-CAM. The sequence has been aligned with the human" and chicken17 sequences already elucidated.
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Figure 3. Patterns of exon usage in C-2 myoblasts and C-2 myotubes, assigned by the numbers of clones isolated and sequenced for each isoform. Exons are patterned
as in Figure 1. The putative splicing patterns required to produce these combinations are also shown.
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Figure 4. Demonstration that PCR maintains the original ratio between N-CAM cDNA isoforms. a). cDNAs were co-amplified in a series of PCRs to assess the
linearity of PCRs. The initial concentrations of the cDNAs incorporated as standards are shown in the table below. The absorbance reading obtained by laser densitometry
was corrected for the number of A + T residues and for loading differences as assessed by the absorbance reading of the internal standard, and is also shown below.
12-13 (fmol)
corrected
absorbance
12-a-b-c-13
(fmol)
corrected
absorbance
I
242
12.3
3.95
0
2
233
12.0
19.8
1.36
3
220
10.7
39.5
2.25
4
196
8.00
79.0
4.70
Track number
5
147
7.05
158
8.77
6
98.0
5.95
237
11.0
7
49.0
3.5
316
13.0
8
24.5
0.%
355
13.4
9
12.25
0 70
375
10.3
10
2.45
0.23
391
15.2
b). The initial concentration of cDNA standard was plotted against the absorbance reading, after correction for A+T residues and internal standard. Open boxes
represent results obtained from amplification of cDNA encoding the isoform 12-13, circles represent results obtained from amplification of cDNA encoding the
isoform 12-a-b-c-13. The concentration of each cDNA was determined by the absorbance of an original stock solution at 260nm. These were then diluted to produce
the initial standard solutions, c). The percentage of one substrate as a proportion of the total substrate plotted against the relative intensity of the band produced
on a gel (after correction for A+T content). The straight line has the equation y = 3.1533 + 0.9367x.
starting concentrations were varied systematically. A third
substrate (cDNA 12— la-13) was included at a constant
concentration as a control. The results are shown in Figure 4a.
Incorporation of 32P during the reaction allowed quantification
by laser densitometry of film.
Figure 4b shows the graphs of product yield (absorbance)
versus substrate concentration obtained after analysis of
Figure 4a. For both substrates the relationship was linear and
the substrates were amplified with equivalent efficiencies. This
point is emphasized in Figure 4c, which shows that the starting
ratio of cDNA substrates was maintained during amplification.
From other work (data not shown), we have found that the
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Figure 5. Analysis of N-CAM exon incorporation in mRNA from developing
muscle, a). PCR products from a RT-PCR were re-amplified in the presence
of a[32P] dATP. The products were separated on 10% native polyacrylamide
gels RT-PCR products of RNA from C-2 cells at mononucleate myoblast stage,
mid-fusion (2 days post induction into myogenesis), and multinucleated myotubes
(4 days post induction) are compared to RT-PCR products of RNA from
embryonic, newborn, adult, and 7 day post surgically denervated skeletal muscle.
Two markers include cDNAs previously isolated from the cloning and sequencing
of RT-PCR products of mRNA from C-2 myoblasts and myotubes. cDNA marker
C includes the isoforms 12-13, 12-a-13, 12-a-c-13, and 12-a-b-c-13. cDNA marker
CA includes 12-AAG-13, 12-a-AAG-13, 12-C-AAG-13 and 12-a-b-c-AAG-13.
b). PCR products were reamplified and separated as previously described, but
using a primer directed against exon MSDlc with the primer against exon 13.
The inclusion of the triplet AAG exon in RNA from embryonic, newborn, adult
and 7 day post surgically denervated skeletal muscle is compared to the expected
size of re-amplified cDNA control. cDNA marker C includes the isoforms 12-13,
12-a-13, 12-a-c-13, and 12-a-b-c-13. cDNA marker CA includes 12-AAG-13,
12-a-AAG-13, 12-C-AAG-13 and 12-a-b-c-AAG-13. The bands obtained from
PCR of RT-PCR product derived from adult muscle required a longer exposure
than the other PCR products. The band marked with an asterisk is thought to
be due to partial denaturation of PCR product.
amplification reactions affect ratios when the levels of product
are much higher, probably due to the depletion of dNTP
substrates. The product yields from a second amplification
reaction of 15 cycles applied to the first RT-PCR reaction
products were much lower than those produced by the test
reactions in Figure 4, and so we conclude that the second
Nucleic Acids Research, Vol. 19, No. 17 4713
amplification would maintain the input ratios of cDNA isoforms.
We infer also that the same applied to the first amplification
reaction, where the substrate was the product of reverse
transcription of mRNA. The starting concentrations were very
low and, even after 30 cycles, the products were very scarce
(the yield of N-CAM cDNA would be approximately 0.3% of
that produced after the second amplification). We conclude that
the PCR strategy used was valid, in that it would maintain the
ratios of cDNA isoforms produced by reverse transcription.
Exon usage in developing muscle
The forms of N-CAM mRNA in the MSD region in
differentiating C-2 cell lines and in developing skeletal muscle
cells were studied by analysis of quantitative PCRs using the
strategy with two successive amplification reactions described
above and shown in Figure 1. The PCR products, labelled with
[a-32P] dATP, were run on native polyacrylamide gels.
Eight cDNA clones, derived from N-CAM mRNA from C-2
myoblasts and myotubes as described above, were co-amplified
as markers: C included the variant forms 12-13, 12-a-13, 12-a-
c-13, 12-a-b-c-13 ; CA included 12-AAG-13, 12-a-AAG-13,
12-C-AAG-13, 12-a-b-c-AAG-13. In addition, the identities of
the bands assigned in Figure 5a were confirmed by elution of
the DNA from the gel and subsequent sequence analysis. Two
bands were observed (at 69bp and 149bp) which did not correlate
with any of the cDNAs used as size markers. These bands were
due either to previously uncharacterized patterns of splicing or
the inclusion of a novel exon, or were gel artefacts. To distinguish
the two the bands were excised and sequenced. The sequence
analysis indicated that the two bands were due to apparent
aberrant migration of the 12-13 and 12-a-b-c-13 isoforms. These
rogue bands could have been derived by either of two
mechanisms: the partial denaturation of the RT-PCR product
leading to aberrant migration on a native gel, or the production
of single stranded DNA during the PCR reaction. The production
of ssDNA had not been noted in the amplification of cDNA
markers, derived from the cloned mouse MSD isoforms, in which
much higher concentrations of final product were made using
identical PCR conditions. The production of ssDNA was
therefore thought to be the less likely explanation for the aberrant
migration, and therefore the bands were assigned to the
appropriate category and included in the calculations as such.
Laser densitometry of the autoradiograph shown in Figure 5a
led to the quantification of the cDNA bands; the corrected
intensities are shown in Table 1. The quantification of exon AA-
G usage in conjunction with the exons of the MSD was
undertaken by performing the second PCR with two internal
oligonucleotides, directed at exon c and exon 13. PCR products
produced in this reaction were short enough for the inclusion of
the triplet exon AAG to be determined on a native polyacrylamide
gel. Figure 5b illustrates the inclusion of the triplet AAG exon
in combination with exon c of the MSD. If the profile of
myoblasts, mid-fusion cells, myotubes, embryonic, newborn, and
adult is taken as representative of a developmental profile, clear
shifts in exon usage can be seen (Figure 6). 1) There was a shift
towards inclusion of exons a-b-c as a unit during development.
2) There was a corresponding reduction in triplet AAG
incorporation either alone or in combination with the MSD exons.
3) A transient reduction in triplet AAG usage at mid-fusion (2
days post induction) was superimposed on the general trend
toward reduced incorporation, and is reproducible (data not
shown). 4) Surgical denervation of adult muscle cells caused a
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Table 1.
Proportionate abundance of N-CAM isoforms in muscle cells and tissues.
splicing pattern
% 15-13
% 12-AAG-13
% 12-a-13
% 12-a-AAG-13
% l2-a-b-c-13
* 12-a-b-c-AAG-13
C-2 myoblasts
43
57
<0.5
<0.5
<0.5
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31
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Figure 6. Diagrams showing the proportions of each N-CAM isoform in mRNA from muscle cells and tissues. The proportion of each isoform is shown as a percentage
of total N-CAM mRNA isolated from C-2 myoblasts, C-2 mid-fusion (2 day post induction of myogenic differentiation), C-2 myotubes (4 day post induction) from
cell culture, embryonic, newborn, adult and post surgically denervated skeletal muscle, and analysed by a combined RT-PCR.
shift towards the exon combination 12-a-b-c-13 with reduced
levels of inclusion of the triplet AAG exon.
Exon usage in neural cells
PCR products produced as described above but from neural cell
mRNA were separated on native polyacrylamide gels alongside
the cDNA markers. The PCR products derived from the different
stages of development showed no significant switch in exon usage
although some differences in the prevalence of different isoforms
in normal and transformed cells can be seen (Figure 7). 1) Little
or no incorporation of the MSD exons a,b, and c was detected
in RNA from the brains of mice at different stages of
development. The very low levels of apparent incorporation of
these exons in mRNA isolated from embryonic brain may have
been derived from muscle due to contamination during dissection.
2) Low levels of the previously identified isoforms 12-a-13 and
12-a-AAG-139 were present in embryonic and adult tissues. 3)
The isoform 12-AAG-13 was not found in RNA derived from
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Pigure 7. Analysis of N-CAM exons incorporated in mRNA from brain tissues
and neural cell lines. PCR products were amplified and separated as previously
described. RT-PCR products of RNA from embryonic, newborn and adult mouse
brain is compared with RNA isolated from mouse N2A neuroblastoma, rat C6
glioma, and rat SWA schwannoma. Two control cDNAs described previously
were run as size markers cDNA marker C includes the isoforms 12-13, 12-a-13,
12-a-c-13, and 12-a-b-c-13. cDNA marker CA includes 12-AAG-13, 12-a-AA-
G-13, 12-C-AAG-13 and 12-a-b-c-AAG-13.
normal mouse tissues, but it was detected in RNA isolated from
a mouse neuroblastoma cell line. 4) The same isoform was the
predominant form in rat Glioma and Schwannoma cell lines.
DISCUSSION
The exons comprising the MSD region of humans and chick N-C-
AM have been shown to undergo tissue-specific regulation of
alternative splicing, and recently the developmental variation
between late embryonic and adult N-CAM isoform use has been
elucidated for rat heart muscle. It was not clear whether the exons
comprising the MSD were regulated separately or as a unit; any
evidence of control of individual exons would imply that each
exon makes a separate contribution to the function of N-CAM.
We have characterised the patterns of expression of the mouse
MSD exons during the development of skeletal muscle and brain,
finding clear evidence for major shifts in expression of individual
MSD exons. Cloning and sequencing of the mouse exons
indicated a high level of DNA sequence similarity between man
and mouse: 100%, 77% and 83% for MSDla, MSDlb and
MSDlc respectively.
Correlation of results between cloning and direct analysis
Characterization of the patterns of splicing was achieved by a
coupled RT-PCR, the products of which were either cloned and
sequenced or analysed directly by re-amplification and subsequent
separation on native polyacrylamide gels. The results of the two
methods were compared by a x2 analysis, using the values
obtained for the re-amplification method as expected values for
the cloning method. The comparison showed no significant
difference in the results obtained by the two methods for RNA
isolated from C-2 myoblasts, but did show a difference for those
obtained from RNA isolated from C-2 myotubes. The difference
in the results obtained for the two methods from RNA isolated
from C-2 myotubes appears to be due to a relative lack of the
isoform 12-a-b-c-AAG-13 and an excess of the isoform 12-13
in the direct re-amplification method. The lack of comparability
between the results obtained by the cloning of RT-PCR products,
and the direct re-amplification and subsequent separation on
polyacrylamide gels for RNA isolated from C-2 myotubes may
be due to several factors. A clear possibility is that one or both
of the methods may exhibit poor reproducibility. However the
direct re-amplification procedure was clearly shown to yield linear
and reproducible results, and good correlation with direct cloning
strategies has been shown in other studies23. Alternatively, as
the N-CAM isoform distribution was shown to alter during
development, and, although for both methods RNA was isolated
from cells 4 days after myogenic induction, other factors such
as cell density and quality of sera may affect the exact time course
of differentiation.
Discrete and coordinated regulation of the MSD exons
In mononucleate myoblast C-2 cells the predominant isoforms
of N-CAM excluded the MSD exons, although there were
substantial levels of the triplet exon AAG. During fusion of the
cells the incorporation of AAG declined transiently and MSDla
appeared at a low level; later, in myotubes, the MSDlb and
MSDlc were incorporated, almost exclusively together and in
conjunction with MSDla. During muscle development the MSD
exons were present only as a coordinate unit, but in neural cells
exon MSDla was seen at low levels in brain tissue, with no
mRNA incorporating all the MSD exons. Although other
alternative splicing patterns were found within the MSD, they
were uncommon (12-C-AAG-13, 12-a-c-13). We conclude that
the incorporation of exon MSDla is regulated independently of
exons MSDlb and MSDlc, but that inclusion of the latter two
requires MSDla. Incorporation of the triplet AAG exon does
not appear to require or be coordinated with the MSD exons.
The decline in MSD-containing RNA in adult skeletal muscle,
and the appearance of low levels of MSDla alone, might arise
from an increased contribution of Schwann cells and muscle
satellite cells to the mRNA being analysed. This would be
expected from the nerve-dependent reduction in N-CAM gene
expression as skeletal muscle cells mature, which results in the
loss of N-CAM from all regions except the neuromuscular
junction and the muscle satellite stem cells24.
The most likely process by which the levels of the N-CAM
mRNA isoforms are determined is alternative splicing of the pre-
mRNA. However, different stabilities of the isoforms might
contribute also. The levels appear to be controlled in a tissue-
and stage-specific manner. With the muscle cell lines, such
control could reflect either specific regulation of the determining
process or a general change in the efficiency of the process. In
the case of the tissue samples, changes in the levels of isoforms
during development could arise in the same ways or as a
consequence of altered proportions of different cell types in the
tissue, where each cell type produces a specific set of isofoms.
The question of regulation is particularly intriguing for the AA-
G exon, a separate function for which is implied by its
independent variation in incorporation.
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Effect of denervating muscle
In RNA isolated from skeletal muscle seven days after surgical
denervation the predominant isoform was 12-a-b-c-13; little
inclusion of the triplet exon AAG was detected, and the isoform
12-13 had almost disappeared. Surgical denervation of adult
skeletal muscle is known to cause a marked increase in N-CAM
expression23. The marked shift in exon usage seems to indicate
that N-CAM expression is under post-transcriptional control as
well. The transcriptional regulation involves a single regulatory
unit, which exhibits a GC-rich content and a high frequency of
the dinucleotide CpG but lacks the normal TATA or CCAAT
motifs26. This regulation is poorly understood, although changes
in tissue-specific trans-acting factors, modulation of methylation
state of the region, or the effect of continued electrical stimulation
of cells by nerve impulses may prove to be important. It is very
likely that the apparent switch in splicing results in part from
the nerve-dependent transcriptional activation of multinucleated
myofibres, such that these cells increase their contribution to the
N-CAM mRNA isoforms isolated from the tissue. Likewise, the
contributions of Schwann and satellite cells might be expected
to alter in response to nerve degeneration and muscle atrophy.
Further experiments would be required to show whether splicing
was regulated directly.
Possible role for the MSDla, MSDlb, MSDlc and AAG exons
All combinations of splicing patterns of the MSD exons would
maintain the reading frame, but it is impossible to predict whether
the minor isoforms produced by alternative splicing within this
domain would encode functional N-CAM proteins. The
physiological role of the protein domain encoded by the exons
of the MSD has not been studied in detail, although incorporation
of MSDla may introduce a 'hinge' into the molecule, and the
domain as a whole is known to undergo significant post-
translational modification, notably O-linked glycosylation.
Inclusion of the MSD as a unit has also been shown to induce
enhanced myogenesis in myoblasts which have been transfected
with full length cDNA encoding the MSD27. Inclusion of the
triplet AAG exon results in an insertion of a single amino acid
into the primary structure. In place of arginine, which is found
in all the isoforms that do not incorporate AAG, glutamine and
glycine are encode by the isoforms 12-AAG-13 and 12-a-AA-
G-13, and lysine and glycine by 12-a-b-c-AAG-13. If the
inclusion of the AAG exon is demonstrated to be regulated, these
subtle changes in the amino acid structure may represent an
important point for modulation of cell-cell interaction which is
mediated by the regulation of alternative splicing of an unusually
short exon in N-CAM.
CONCLUSIONS
Eight patterns of alternative splicing were noted in RNA derived
from C-2 mouse muscle cells. These were cloned and sequenced
and resulted in the elucidation of the DNA sequence of the mouse
homologues to exons MSDla, MSDlb, MSDlc and triplet AA-
G in the human. Analysis of PCR amplification of known
amounts of N-CAM cDNA indicated that at low substrate
concentrations the method was linear. This led to the
quantification of isoform use which revealed a significant shift
in isoform use toward inclusion of MSDla, MSDlb and MSDlc,
and a decrease in use of triplet AAG during skeletal muscle
development. A marked switch in isoform use was also seen
between pre- and post-denervated skeletal muscle.
These data indicate that the post-transcriptional processing,
probably due to alternative splicing, of four short exons located
between the constitutively spliced exons 12 and 13 of N-CAM
are under both tissue- and developmental-specific regulation; one
of these exons, the triplet AAG, is only 3 base pairs long and
is regulated independently of the other exons. These findings lead
to interesting questions about the possible mechanisms for the
regulated control of alternative splicing of such unusually short
exons.
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